132 related articles for article (PubMed ID: 16191512)
21. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
[TBL] [Abstract][Full Text] [Related]
22. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies.
Pistoia V; Cocco C; Airoldi I
J Clin Oncol; 2009 Oct; 27(28):4809-16. PubMed ID: 19720917
[TBL] [Abstract][Full Text] [Related]
24. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
[TBL] [Abstract][Full Text] [Related]
25. Diffuse large B-cell lymphoma arising independently to lymphoplasmacytic lymphoma: a case of two lymphomas.
Sekikawa T; Takahara S; Suzuki H; Takeda N; Yamada H; Horiguchi-Yamada J
Eur J Haematol; 2007 Mar; 78(3):264-9. PubMed ID: 17253969
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.
Bench AJ; Erber WN; Follows GA; Scott MA
Int J Lab Hematol; 2007 Aug; 29(4):229-60. PubMed ID: 17617076
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Pérez-Chacón G; Contreras-Martín B; Cuní S; Rosado S; Martín-Donaire T; Losada-Fernández I; Vargas JA; Jordá J; Alvarez N; García-Marco J; Pérez-Aciego P
Am J Clin Pathol; 2005 May; 123(5):646-50. PubMed ID: 15981803
[TBL] [Abstract][Full Text] [Related]
29. Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas.
Gouw LG; Reading NS; Jenson SD; Lim MS; Elenitoba-Johnson KS
Br J Haematol; 2005 May; 129(4):531-3. PubMed ID: 15877735
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
31. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
32. Promoter analysis of epigenetically controlled genes in bladder cancer.
Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
[TBL] [Abstract][Full Text] [Related]
33. Global, comparative analysis of tissue-specific promoter CpG methylation.
Schilling E; Rehli M
Genomics; 2007 Sep; 90(3):314-23. PubMed ID: 17582736
[TBL] [Abstract][Full Text] [Related]
34. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.
Taylor KH; Kramer RS; Davis JW; Guo J; Duff DJ; Xu D; Caldwell CW; Shi H
Cancer Res; 2007 Sep; 67(18):8511-8. PubMed ID: 17875690
[TBL] [Abstract][Full Text] [Related]
35. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
[TBL] [Abstract][Full Text] [Related]
37. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
[TBL] [Abstract][Full Text] [Related]
38. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
39. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma.
Tedoldi S; Mottok A; Ying J; Paterson JC; Cui Y; Facchetti F; van Krieken JH; Ponzoni M; Ozkal S; Masir N; Natkunam Y; Pileri S; Hansmann ML; Mason D; Tao Q; Marafioti T
J Pathol; 2007 Dec; 213(4):429-40. PubMed ID: 17935142
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]